Avantor Names Former CONMED CFO Todd Garner As Finance Chief

Avantor Inc. has appointed Todd Garner, the most recent chief financial officer at medical-device maker CONMED Corporation, as its next CFO. The selection brings a finance chief with public-company CFO credentials into the top finance seat at Avantor, a global supplier of products and services to the life-sciences and applied-materials industries.

The appointment, as reported by Pulse 2.0, does not name a start date, an interim arrangement or compensation terms in the initial announcement. Investors should expect those specifics in a Form 8-K filing the company will submit to the Securities and Exchange Commission.

What is the change?

The CFO seat shifts to an executive who held the CONMED chief financial officer post before his departure. CONMED Corporation, listed on the New York Stock Exchange under the ticker CNMD, develops surgical devices and equipment for orthopedic, general surgery and gynecological applications, alongside a broader portfolio of healthcare technology. Avantor trades under the ticker AVTR.

Garner takes over a finance function that supports a global distribution footprint spanning biopharma, healthcare, education and advanced-technology customers, with operations in more than 30 countries.

What does the timeline look like?

Public companies typically formalize CFO transitions through a Form 8-K filing within four business days of the appointment. That document usually discloses the effective date, base compensation, annual cash bonus targets, long-term equity awards and any make-whole payments tied to awards forfeited at the prior employer. Total compensation for new CFOs at mid-cap NYSE-listed companies with global operations generally falls in a $4 million to $8 million annual range, weighted toward equity.

Until an 8-K lands, the headline confirmation serves as the first signal. Sell-side analysts and corporate treasury teams will read the filing for the size of the signing package, the vesting schedule on the initial equity grant, and whether the outgoing CFO remained through a transition period.

What should CFOs and finance teams track?

For finance leaders at peer suppliers, the hire signals continued board appetite for CFOs with public-company credentials and prior P&L ownership. A chief financial officer who has run the finance function at another NYSE- or NASDAQ-listed company typically arrives with established sell-side relationships, fluency in non-GAAP reporting frameworks, and a track record on working-capital management.

Inside Avantor, the incoming finance chief inherits an organization supporting multi-currency revenue, a customer base split between regulated life-sciences buyers and industrial end-markets, and a balance sheet that reflects several years of acquisition-driven growth. That scope typically demands disciplined treasury management, active foreign-exchange hedging, and tight cash-conversion metrics on the next quarterly call.

What is the forward implication?

The hire does not, on its own, signal a shift in capital-allocation policy, leverage targets or reporting cadence. Boards typically give incoming CFOs a 90- to 180-day window to review the finance organization, audit relationships and the forward forecast before articulating any changes to investors.

Until that review completes, segment guidance, dividend policy and any existing buyback authorization are expected to remain on the trajectory set under prior finance leadership. The first formal test of the new finance chief will arrive on the next scheduled quarterly earnings call.